Showing posts with label Neonatology. Show all posts
Showing posts with label Neonatology. Show all posts
Tuesday, September 1, 2015
Friday, August 15, 2014
Infant with Conjugated Hyperbilirubinemia
Gestational alloimmune liver disease and neo... [Semin Liver Dis. 2012] - PubMed - NCBI http://t.co/CIUBLA43gw
— Emily Eresuma (@eEresuma) August 15, 2014Infant with Conjugated Hyperbilirubinemia by Nora Switchenko M.D.
Wednesday, July 30, 2014
Monday, July 28, 2014
Tuesday, July 22, 2014
Monday, July 14, 2014
Wednesday, July 9, 2014
Tuesday, July 8, 2014
Monday, January 6, 2014
Monday, November 4, 2013
Tuesday, June 11, 2013
Monday, April 15, 2013
Wednesday, February 6, 2013
Friday, November 2, 2012
Wednesday, August 22, 2012
Friday, April 20, 2012
Wednesday, March 21, 2012
Neonatal Thrombocytopenia 03.23.2012
Thrombocytopenia in the Neonatal Intensive Care Unit
Matthew A. Saxonhouse andMartha C. Sola-Visner
Neoreviews September 2009; 10:e435-e445
Abstract
As the survival of neonates cared for in the neonatal intensive care unit (NICU) has improved, hematologic issues have been recognized as clinically significant problems in this population. Thrombocytopenia, in particular, is a common finding among sick neonates, but there is considerable debate regarding the appropriate evaluation and management of affected infants. This article provides state-of-the art information on the pathophysiology, diagnosis, and treatment of neonatal thrombocytopenia. Specifically, the risks associated with low platelet counts in neonates are discussed, and a practical approach to the differential diagnosis of neonates who develop thrombocytopenia is provided. Current recommendations for the management of immune and nonimmune varieties of thrombocytopenia also are reviewed, with an emphasis on the risks and benefits associated with platelet transfusions in this age group.
Matthew A. Saxonhouse andMartha C. Sola-Visner
Neoreviews September 2009; 10:e435-e445
Abstract
As the survival of neonates cared for in the neonatal intensive care unit (NICU) has improved, hematologic issues have been recognized as clinically significant problems in this population. Thrombocytopenia, in particular, is a common finding among sick neonates, but there is considerable debate regarding the appropriate evaluation and management of affected infants. This article provides state-of-the art information on the pathophysiology, diagnosis, and treatment of neonatal thrombocytopenia. Specifically, the risks associated with low platelet counts in neonates are discussed, and a practical approach to the differential diagnosis of neonates who develop thrombocytopenia is provided. Current recommendations for the management of immune and nonimmune varieties of thrombocytopenia also are reviewed, with an emphasis on the risks and benefits associated with platelet transfusions in this age group.
Subscribe to:
Posts (Atom)